PF
BSX icon

Phoenix Financial’s Boston Scientific BSX Stock Holding History

Phoenix Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,000
Closed -$941 – 533
2026
Q1 		$941 Buy
+15,000
New +$1.2M ﹤0.01% 486
2024
Q1 		– Sell
-12,800
Closed -$740 – 434
2023
Q4 		$740 Buy
+12,800
New +$683K ﹤0.01% 343

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Phoenix Financial's BSX Position: Q2 2026 in Review

Phoenix Financial increased its Boston Scientific (BSX) stake by 27% in Q2 2026, buying an estimated $22.4M and bringing the position to 1,962,730 shares worth $83.8M. The position accounts for 0.57% of the portfolio, ranked #45.

Phoenix Financial first reported a position in BSX in Q3 2020 and has held it in 24 quarters since. The position peaked at $97.3M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Phoenix Financial held 1,962,730 shares of Boston Scientific worth $83.8M as of Q2 2026.
  • Phoenix Financial bought 412,358 Boston Scientific shares in Q2 2026, an estimated $22.4M.
  • Boston Scientific made up 0.57% of Phoenix Financial's portfolio in Q2 2026, its #45 holding.
  • Phoenix Financial first reported a position in Boston Scientific in Q3 2020 and has held it in 24 quarters since.
  • Phoenix Financial's Boston Scientific position peaked at $97.3M in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.